About this trial
Investigastors hypothesis is that the need for anaesthetic agents is less in patients with high progesterone levels and more in patients with high estrogen levels.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Between 18-45 years old
ASA-I ASA-II patients who were sedated for oocyte pick-up between 1 June 2025 and 1 September 2025 at Izmir City Hospital
Patients whose hormone levels were measured in the preoperative period due to surgical indication and registered in the hospital data processing system
Disqualifiers
Lack of patient approvel
Diagnosed psychiatric disorder
Use of drugs affecting the central nervous system
Presence of chronic pain syndrome
Trial population
Between 18-45 years old * ASA-I ASA-II patients who were sedated for oocyte pick-up between 1 June 2025 and 1 September 2025 at Izmir City Hospital * Patients whose hormone levels were measured in the preoperative period due to surgical indication and registered in the hospital data processing system
Trial design
Other
Cross-sectional
Treatments tested in this trial
Anesthesia Maintenance
Drugthe amount of propofol required to achieve depth of anaesthesia in mg/kg/minute
Treatment groups
Trial outcomes
Primary outcomes
Anesthetic consumptiom
the amount of propofol needed to provide adequate depth of anaesthesia in mg/kg/minute
Secondary outcomes
Pulse oximeter
pulse oksimeter values at the begining, 10 minutes later and final
hearth rate changes
Heart rate (bp/min) at the begining, 10 minutes later, final
Blood pressure changes
Blood pressure values (mm/Hg) at the begining, 10 minutes later, final
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: